Maxwell Biomedical, Inc
Maxwell Biomedical, Inc., located in San Diego, CA, is pioneering advancements in the treatment of atrial fibrillation (AF) and heart failure with preserved ejection fraction (HFpEF) through its innovative Rhythm360 system. This first-in-class atrial synchronization therapy utilizes an AI-driven implantable device designed to restore sinus rhythm and synchronize atrial contractions without damaging cardiac tissue.
Committed to addressing critical unmet needs in AF treatment, Maxwell Biomedical is expanding its clinical study to validate the groundbreaking Spatial Resynchronization Therapy (SRT), which aims to enhance atrial heart function while preventing AF. By focusing on non-destructive approaches rather than conventional tissue destruction methods, Maxwell Biomedical is driving a paradigm shift in AF care, ultimately improving patient outcomes worldwide.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.